Can You Overdose on Eyedrops? What to Know

Eyedrops can absolutely cause a dangerous overdose, and the risk is more real than most people assume. Swallowing even a small bottle of common over-the-counter redness-relief drops has sent adults to the hospital with life-threatening heart rhythm problems, and certain prescription drops have caused breathing failure in infants just from normal topical use. The danger varies dramatically depending on the active ingredient, the amount involved, and the person’s age and size, but the core issue is that eyedrops are medications, and their active ingredients reach the bloodstream far more efficiently than most people realize.

How Eyedrops Get Into Your Bloodstream

Most people think of eyedrops as purely local treatments. You put them in your eye, they work on your eye, end of story. But that is not what happens. After a drop lands on your eye, a large portion of it drains through the tear duct into the nasal cavity. The inside of your nose is lined with tissue packed with blood vessels, and when an eyedrop’s active ingredient hits that tissue, it absorbs quickly into the bloodstream without first passing through the liver.

¹

That last detail matters. When you swallow a pill, it travels through your gut and into the liver before reaching general circulation. The liver metabolizes a chunk of the drug before it ever reaches the rest of your body. Eyedrops bypass that filter entirely. The active ingredient that drains from your eye into your nose enters the bloodstream in a relatively unmetabolized form, which is why even small volumes of certain drops can produce whole-body effects that seem wildly disproportionate to the tiny amount applied.

Over-the-Counter Redness Relievers and Ingestion

The most notorious overdose risk comes from OTC drops marketed to “get the red out.” Products containing tetrahydrozoline or naphazoline are vasoconstrictors: they shrink the tiny blood vessels in your eye to make redness disappear. These ingredients belong to a class called imidazolines, which act on receptors in the nervous system. When someone swallows a bottle’s worth, the systemic effects hit hard.

A case report documented a 76-year-old man who ingested roughly eight bottles of tetrahydrozoline-containing drops and developed complete heart block, meaning the electrical signals coordinating his heartbeat stopped being conducted properly. His heart rate dropped dangerously, and his ECG showed prolonged QT intervals, a pattern associated with fatal arrhythmias.² The primary systemic effects of imidazoline ingestion are bradycardia (dangerously slow heart rate) and hypotension (low blood pressure), driven by stimulation of receptors in the brain that dial down cardiovascular output. Other reported symptoms include pinpoint pupils, dry mouth, depressed consciousness, slowed breathing, low body temperature, and diminished reflexes.³

These cases are not limited to suicide attempts. Criminal poisoning with eyedrops has been prosecuted in the United States, where people have spiked drinks with tetrahydrozoline. The ingredient is colorless and nearly tasteless in water, making it difficult to detect. An amount that sounds trivially small, a few milliliters, can cause serious cardiovascular collapse in an unsuspecting person. If you suspect someone has ingested eyedrops, this is a call-911 situation, not a wait-and-see one.

Prescription Eyedrops That Cause Systemic Side Effects at Normal Doses

You do not have to swallow prescription eyedrops for them to cause problems. Several classes of prescription drops are potent enough that the small fraction absorbed through the tear duct and nasal mucosa can produce meaningful effects throughout the body. This is not theoretical; it shows up in clinical data across multiple drug classes.

Beta-Blocker Drops

Timolol and other beta-blocker eyedrops are widely prescribed for glaucoma. They lower eye pressure by reducing fluid production inside the eye, but once absorbed systemically, they do the same thing beta-blocker pills do: slow the heart and constrict the airways. For people with asthma, this is a serious concern. A study combining real-world data and a meta-analysis of clinical trials found that a single acute exposure to nonselective beta-blocker eyedrops nearly quintupled the rate of moderate asthma flare-ups, and caused an average drop in lung function of about 11 percent, with roughly one in three patients experiencing a clinically significant decline.⁴ That is from a single drop in the eye, not from swallowing anything.

Alpha-2 Agonist Drops

Brimonidine is another common glaucoma drop. In adults, it is generally well tolerated, but in young children it can be dangerous. Post-marketing surveillance revealed serious enough side effects that brimonidine is now banned for use in children under two years old.⁵ In a review of 176 children exposed to brimonidine, the most common symptom was drowsiness (about 41 percent of cases), followed by loss of coordination, pallor, irritability, low blood pressure, slow heart rate, pinpoint pupils, and depressed breathing.⁶

The clinical picture in small children can mimic opioid overdose, with unresponsiveness, lethargy, shallow breathing, and stupor. A case report described transient encephalopathy in a toddler after accidental brimonidine exposure, confirmed later by toxicology testing.⁷ Premature infants are even more vulnerable. Three preterm neonates developed depression of both the central nervous system and respiratory function within two hours of receiving a combination of brimonidine and timolol eyedrops, effects that persisted for a prolonged period.⁸

Anticholinergic (Mydriatic) Drops

Drops like atropine, cyclopentolate, and tropicamide are used to dilate the pupil during eye exams and to treat certain inflammatory conditions. Their active ingredients block acetylcholine receptors, and when absorbed systemically, they can cause the full anticholinergic syndrome: flushed skin, dry mouth, fast heart rate, agitation, confusion, hallucinations, and in severe cases, seizures and coma. A pediatric case report described a child who developed both central and peripheral anticholinergic syndrome after exposure to mydriatic drops.⁹ In one case involving deliberate ingestion of atropine eyedrops by an adult, emergency physicians had to administer repeated large doses of an antidote (physostigmine, totaling 14 mg) to reverse the toxicity and avoid intubation.¹⁰

Why Children Face Greater Risk

Children turn up repeatedly in eyedrop toxicity reports for a straightforward reason: their bodies are small, so even a fraction of a standard adult drop delivers a proportionally larger dose per kilogram. A single drop of brimonidine that barely registers in a 70-kilogram adult is a significant exposure for a 5-kilogram infant. Young children also tend to encounter these products accidentally, either grabbing a bottle from a countertop or having drops prescribed at doses calibrated for an older patient.

The symptoms in children often develop fast, within an hour or two, and can be alarming. Extreme sleepiness progressing to unresponsiveness is the hallmark of brimonidine toxicity in young kids, and it is easy to mistake for a nap in a very young child unless a caregiver knows to suspect the drops.⁶ The practical takeaway is simple: treat all eyedrop bottles like medications. Store them out of a child’s reach. If a child ingests eyedrops or shows sudden unexplained drowsiness or breathing changes after drops are used near them, contact poison control or go to an emergency room immediately.

Chronic Overuse of Redness-Relief Drops

Even without a dramatic acute overdose, habitual use of OTC redness-relief drops creates its own problems. The vasoconstrictors in these products, particularly those with alpha-1 adrenergic activity, lose effectiveness over time as the eye’s blood vessels adapt. This is called tachyphylaxis. Users notice the drops stop working as well, so they use them more frequently, which deepens the cycle. When they finally stop, the blood vessels dilate wider than they were before treatment, producing rebound redness that looks worse than the original problem.¹¹

This rebound effect, sometimes called conjunctivitis medicamentosa, has been documented after days, weeks, or months of continuous use of drops containing naphazoline or tetrahydrozoline. The mechanism involves ischemia: when you chronically constrict blood vessels, the surrounding tissue becomes starved for oxygen and releases signals demanding more blood flow, so when the constricting drug wears off, the vessels dilate aggressively. The result is that people who started using redness drops for a minor cosmetic annoyance end up with chronically red eyes that feel dependent on the drops. Breaking the cycle means stopping the drops entirely and tolerating a period of worse-than-baseline redness while the blood vessels normalize.

Preservative Concerns With Long-Term Use

Beyond the active ingredient, the preservatives in many eyedrop formulations deserve attention for anyone using drops regularly. Benzalkonium chloride (BAK) is the most common preservative in eyedrops, and it is a potent disruptor of cellular function. Laboratory research has shown that BAK inhibits mitochondrial oxygen consumption in corneal cells at concentrations 25 to 150 times lower than the concentrations actually used in commercial eyedrops.¹²

For someone using a single drop once in a while, this is not clinically meaningful. But for glaucoma patients who use preserved drops multiple times a day for years, cumulative BAK exposure can contribute to ocular surface disease, chronic inflammation, and discomfort that complicates their treatment. This is one reason why preservative-free formulations have become increasingly available and why eye care professionals often recommend them for patients on long-term drop regimens.

How to Reduce Systemic Absorption When Using Drops

If you use prescription eyedrops, especially ones known for systemic side effects like timolol or brimonidine, a simple technique can significantly reduce how much medication drains into your nose and enters your bloodstream. After instilling a drop, close your eyes gently and press a finger against the inner corner of your eye, near the bridge of your nose. Hold for one to two minutes. This is called nasolacrimal occlusion, and it physically blocks the drop from draining through the tear duct into the nasal passage.¹³

Research supports that this technique both improves how much medication reaches the eye itself and reduces absorption into the rest of the body. Simply keeping the eyes closed for the same duration (without pressing the inner corner) also helps, though the combination is most effective. An alternative approach called the “tissue press method” has been proposed as easier to perform correctly, since many patients struggle with the finger-pressure technique.¹⁴ The basic principle is the same: keep the drop in contact with the eye and out of the nose. Despite being simple and well supported, this technique is rarely taught to patients, which is a missed opportunity given how much it can reduce side effects.

Eyedrops and Pets

Dogs are particularly vulnerable to eyedrop toxicity because they tend to chew on anything they find, including dropped bottles. A retrospective study of 52 dogs that ingested brimonidine eyedrops found that about two-thirds developed bradycardia, nearly half showed depression, and significant proportions experienced low blood pressure, weakness, and hypothermia.¹⁵ The study’s authors classified brimonidine ingestion in dogs as dangerous, and the pattern of cardiovascular collapse closely resembles what happens in human children.

If your dog chews through an eyedrop bottle, do not wait for symptoms. Call your veterinarian or an animal poison control hotline. The volume of medication in even a single small bottle is enough to harm a medium-sized dog, and toy breeds face proportionally greater risk.

Contamination as a Different Kind of Risk

Overdose is not the only danger hiding in an eyedrop bottle. Bacterial contamination of eye drops, particularly artificial tears and lubricating drops, has caused serious infection outbreaks. Research on contamination risk found that using contaminated eyedrops carried a meaningfully higher risk of eye infection than other contaminated household products, with risk estimates ranging from one in ten to one in ten thousand per exposure event depending on the pathogen load and exposure frequency.¹⁶ Infections caused by drug-resistant strains of Pseudomonas aeruginosa in contaminated artificial tear products have led to outcomes as severe as loss of an eye.

The contamination issue is separate from the overdose question but matters for anyone using eyedrops routinely. Basic precautions include not touching the dropper tip to your eye or any other surface, not sharing bottles, discarding opened bottles after the recommended period (usually four weeks for preservative-free multi-dose bottles, sooner if you notice cloudiness or particles), and washing your hands before application.

Recreational Abuse of Eyedrops

An unexpected dimension of the eyedrop-risk landscape involves deliberate misuse for psychoactive effects. Over the past 15 years, reports from Europe have documented increasing nonmedical use of tropicamide, an anticholinergic drop used during eye exams. It has gained a reputation as a cheap substitute for heroin, particularly in Eastern European countries where opioid addiction rates are high.¹⁷ Users inject the solution intravenously, which carries extreme risks from both the active ingredient and the preservatives and buffers not designed for injection. This pattern of misuse has been linked to drug-related deaths and is considered an emerging public health concern in regions where it occurs. It is rare in North America but worth knowing about as an illustration of how eyedrop ingredients can be far more pharmacologically active than their packaging suggests.

What to Do If Someone Ingests Eyedrops

The response depends on the product and the amount. For any ingestion beyond a stray drop accidentally swallowed during application, contact poison control (in the United States, the number is 1-800-222-1222) or call emergency services. Bring the bottle with you or have it nearby so you can identify the active ingredient and concentration. Do not induce vomiting unless specifically instructed by a medical professional.

Symptoms from imidazoline ingestion (tetrahydrozoline, naphazoline) tend to appear within 30 minutes to two hours: drowsiness, slow heart rate, low blood pressure, and cold or pale skin. In children, the window can be even shorter. With anticholinergic drops like atropine, the opposite pattern emerges: a fast heart rate, flushed skin, dilated pupils, and agitation. Both presentations warrant emergency evaluation. Treatment in the hospital is mainly supportive, maintaining blood pressure, heart rhythm, and breathing, with specific antidotes available for certain poisoning patterns (physostigmine for anticholinergic toxicity, naloxone sometimes trialed for brimonidine toxicity in children). Most patients recover fully with appropriate care, but delays in seeking treatment allow complications to become more dangerous.